Skip to the content

Neuralix

Scientific research and experimental development in the field of biotechnology

NEURALIX - Scientific research and experimental development in the field of biotechnology and other natural, medical, and technical sciences; technical testing and analysis; production of food products and dietary supplements; production of medical devices, instruments, and apparatus; development, implementation, and maintenance of software and digital products.

Projects:

"METHOD OF TARGETED DESTRUCTION OF AMYLOID FIBRILS IN A GRADIENT MEDIUM FOR POST-COVID COMPLICATIONS"

A comprehensive proprietary MedTech platform integrating: author's clinical protocols, scalable hardware and software complexes, targeted nanocomposites, and specialized support products for a holistic cycle of post-COVID recovery under a B2B2C model.

The computational model precisely describes the Coulomb interaction of charged particles (nanocomposites interacting with molecular targets), which minimizes the use of abstract empirical assumptions.

Olha Podorovska, CEO & Managing Director of NEURALIX Ltd.

Email: neuralix.sof@gmail.com   Phone: +359 88 566 1430

© 2026 Neuralix

Powered by WordPress

To the top ↑ Up ↑